Image

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function

Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of the study is to

  1. To describe the bone morphology in patients with reduced renal function and high or low parathyroid hormone (PTH) respectively.
  2. To investigate if the non-invasive method 18-Fluoride Positron Emission Tomography (18F-PET) can describe the bone turnover and reflect the bone histomorphologic changes
  3. To investigate if non-oxidized PTH reflects bone turnover

Description

Patients with reduced renal function and suspected high turnover or low turnover bone disease are recruited.

A bone biopsy and a 18F-PET scan are performed and it is investigated if the 18F-PET can discriminate high turnover from low turnover bone disease

Eligibility

Patients with reduced renal function:

Inclusion Criteria:

-≥ 18 years

  • estimated Glomerular Filtration Rate (eGFR) ≤ 20 ml/min/1,73m2
  • PTH < 150 pg/ml or PTH > 300 pg/ml

Exclusion Criteria:

  • ongoing malignancy
  • Allergy towards tetracyclin
  • Pregnancy

Control Group:

Inclusion Criteria:

-≥ 18 years

  • eGFR >= 60 ml/min
  • under examination for c prostata
  • Prostatic Specific Antigen (PSA) total <40 µg/l
    Exclusion
  • Former kidney disease
  • ionized calcium or PTH outside normal range
  • Known metabolic bone disease
  • treatment with anticoagulants
  • Disturbed thrombosis and hemostasis

Study details
    Renal Osteodystrophy

NCT03716128

Ditte Hansen

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.